FindTrial
Sign In

A prospective study on the treatment with autologus endometrial stem cells transplantation.

A prospective study on the treatment with autologus endometrial stem cells transplantation.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016769
Enrollment
Unknown
Registered
2018-06-22
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thin endometrium

Interventions

Group1:Hormonal manipulation
Group2:autologus endometrial stem cells transplantation and Hormonal manipulation

Sponsors

Xiangtan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 20 and 40 years; 2. Endometrial thickness < 6 mm; 3. Presence of menstrual bleeding with Natural Cycle; 4. Normal liver, heart, and kidney function; 5. Absence of HIV, Hepatitis B or C, syphilis and psychiatric pathology; 6. Serum ß-hCG is negative.

Exclusion criteria

Exclusion criteria: Having a history of malignant tumor

Design outcomes

Primary

MeasureTime frame
Endometrial thickness;—

Secondary

MeasureTime frame
Endometrial blood flow;Endometrial volume;Ongoing pregnancy rate;—

Countries

China

Contacts

Public ContactTan Xiaojun

Xiangtan Central Hospital

Changdaot@163.com+86 13087329800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026